Basic characteristics of studies (teletransmission vs usual care) included in the meta-analysis
| Author (year) | Comparison | Patient number (N) | Age* | Male (%) | NYHA grade | LVEF (%)* | Follow-up |
|---|---|---|---|---|---|---|---|
| Lyngå (2012)42 | Teletransmission (BW) | 166 | 73.7 (9.9) | 76 | III/IV | <30%: 102 (61.4) | 12 months |
| 30–39%: 34 (20.5) | |||||||
| 40–49%: 30 (18.1) | |||||||
| Without monitoring the BW | 153 | 73.5 (10.4) | 74 | <30%: 80 (52.3) | |||
| 30–39%: 40 (26.1) | |||||||
| 40–49%: 33 (21.6) | |||||||
| Pekmezaris (2012)45 | Teletransmission (BP, stethoscope) | 83 | 81 (7) | 43 | I–IV | NA | 30 and 90 days |
| Usual care | 85 | 83 (7) | 33 | NA | |||
| Wade (2011)51 | Teletransmission (BW, BP) | 164 | 75.8 (6.96) | 51 | NA | NA | 12 months |
| Usual care | 152 | 77.7 (6.97) | 49 | NA | |||
| Koehler (2011)38 | Teletransmission (BW, BP) | 354 | 66.9 (10.8) | 81 | II/III | 26.9 (5.7) | 26 months |
| Usual care | 356 | 66.9 (10.5) | 82 | 27.0 (5.9) | |||
| Weintraub (2010)53 | Teletransmission (BW, BP, HR) | 95 | 69.5 (14.2) | 63 | I–IV | 32.1(17.2) | 90 days |
| Usual care | 93 | 68.5 (12.8) | 69 | 27.2 (15.8) | |||
| Mortara (2009)44 | Teletransmission (vital signs, stethoscope) | 101 | 59 (11) | 84 | II–IV | 28 (8) | 12 months |
| Usual care | 94 | 60 (12) | 89 | 29 (7) | |||
| Scherr (2009)47 | Teletransmission (BW, BP, HR) | 66 | 66 (62, 73)† | 70 | II–IV | 25 (20–38)† | 6 months |
| Usual care | 54 | 67 (61, 72)† | 72 | 29 (21–36)† | |||
| Giordano (2009)6 | Teletransmission (ECG) | 230 | 58 (10) | 84 | II–IV | 28 (7) | 1 year |
| Usual care | 230 | 56 (10) | 86 | 26 (8) | |||
| Dar (2009)5 | Teletransmission (BW, BP, HR, S/S) | 91 | 70 (12.8) | 68 | II–IV | >40%: 33/85 (39) | 3 and 6 months |
| Usual care | 91 | 72 (10.4) | 65 | >40%: 33/83 (40) | |||
| Kashem (2008)36 | Teletransmission (BW, BP, HR) | 24 | 53 (10) | 72 | II–IV | 25 (3) | 1 year |
| Usual care | 24 | 54 (11) | 76 | 26 (3) | |||
| Antonicelli (2008)18 | Teletransmission (ECG, BP, HR, BW) | 28 | 77 (8) | 57 | II–IV | 35 (6) | 12 months |
| Usual care | 29 | 79 (6) | 66 | 37 (7) | |||
| Balk (2008)19 | Teletransmission (BW, BP) | 101 | 68 (33, 85)‡ | 64 | I–IV | 31 (9, 69)‡ | 288 days |
| Usual care | 113 | 65 (42, 87)‡ | 75 | 31 (11, 71)‡ | |||
| Soran (2008)49 | Teletransmission (BW) | 160 | 76.9 (7.1) | 31 | II–III | 24.3 (8.8) | 6 months |
| Standard care | 155 | 76.0 (6.8) | 39 | 23.8 (8.7) | |||
| Woodend (2008)54 | Teletransmission (BW, BP, ECG) | 62 | 67 (13) | 74 | II–IV | NA | 1 year |
| Usual care | 59 | 66 (11) | 70 | NA | |||
| Dansky (2008)26 | Teletransmission (BW, BP, HR, digital stethoscope) | 45 | 78.11 (7.11) | NR | NR | NA | 120 days |
| Usual care | 112 | 76.88 (10) | NR | NA | |||
| Cleland (2005)25 | Teletransmission (BW, BP, ECG) | 168 | 67 (13) | 80 | I–IV | 25 (8) | 240 days |
| Usual care | 85 | 68 (10) | 82 | 24 (8) | |||
| Capomolla (2004)23 | Teletransmission (BW, BP, HR, S/S) | 67 | 57 (10) | 93 | II–IV | 29 (8) | 12 months |
| Usual care | 66 | 57 (10) | 83 | 28 (7) | |||
| Goldberg (2003)34 | Teletransmission (BW) | 138 | 57.9 (15.7) | 70 | III–IV | 21.6 (6.8) | 6 months |
| Usual care | 142 | 60.2 (14.9) | 66 | 21.8 (6.8) | |||
| Benatar (2003)20 | Teletransmission (BW, BP, HR, SatO2) | 108 | 62.9 (13.2) | 36 | III–IV | 38.05 (13.70) | 12 months |
| Usual care | 108 | 63.2 (12.6) | 38 | 38.83 (13.97) | |||
| de Lusignan (2001)27 | Teletransmission (BW, BP, HR) | 10 | 75.2 | n/a | I–IV | NA | 12 months |
| Usual care | 10 | n/a | NA | ||||
| Jerant (2001)35 | Teletransmission (digital stethoscope) | 13 | 66.6 (10.9) | 46 | II–IV | NA | 180 days |
| Usual care | 12 | 72.7 (11.4) | 50 | NA |
*Data expressed as mean±SD.
†Data expressed as median (IQR).
‡Data expressed as median (range).
AHA, American Heart Association; BP, blood pressure; BW, body weight; HFSA, Heart Failure Society of America; HR, heart rate; ICD/CRT, implantable cardiac defibrillator/cardiac resynchronization therapy; LVEF, left ventricular ejection fraction; NA, not available; NR, not reported; NYHA, New York Heart Association Grade; RCT, randomized controlled trial; RPM, remote patient monitoring.